Dr Joseph Fuhr: The Immediate Economic Impact of Biosimilars May be Limited

Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, sees a limited economic impact for biosimilars given current patent disputes.

Transcript (slightly modified)

What will be the immediate economic impact of biosimilars?

In the next few years I see very little economic impact (of biosimilars). There are currently 2 in the market and they are both risk launches. All are involved in various patent disputes and the Supreme Court is looking at 2 issues concerning the 180-day notice of entry and the other concerning whether the patent dance is mandatory.

As with any new industry, [biosimilars] will take time to develop and so their economic impact will be minimal.